- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03088007
Importance of Multidimensional Assessments in Accompanying Schooling of Children With Mild to Moderate Intellectual Disability. (EVAL'ID)
The EVAL'ID study aims to demonstrate the value of a multidimensional assessment in accompanying schooling of children with Intellectual Disability. The study will be performed in the Rhône department (France) in children aged from 5 to 13 years with mild to moderate Intellectual Disability , and attending school either at ULIS (Unités Localisées pour l'Inclusion Scolaire, which enables disabled children to attend regular schools), or IME (Instituts Médico-Educatifs, which are special schools mandated to accommodate children and young people with Intellectual Disability at any level of disability). A multidimensional assessment encompasses the assessment of academic, cognitive, behavioral and adaptive skills of the children, with validated and reliable neuropsychological batteries, called ID Kit (Intellectual Deficiency assessment Kit), which includes the following scales : the Wechsler Intelligence Scale for Children 4th edition (WISC-IV), the Vineland Adaptive Behavioral Scale II, the GECEN rating form (Grille d'Evaluation Comportementale pour Enfants Nisonger, which is the French translation of the Nisonger Child Behavior Rating Form), and an academic skills rating form (GEVA-SCO). A comparison of the children neuropsychological profiles according to the type of school they attend, will be perform.
The project consists of three phases:
- Stage 1: Collection of information from each child records at MDPH (Departmental Administration for Disabled Persons), IME, ULIS schools, including the assessments that were performed, and from a survey of both caregivers and parents regarding their respective perception and knowledge of the child's disability
- Stage 2: All the children who were not previously assessed with the ID kit will be further evaluated using these tests. The results of these assessments will be shared with parents and caregivers.
- Stage 3: A survey regarding the perception and knowledge of the child's disability will be carried out again among caregivers and parents.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69500
- Hospices Civils de Lyon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age : > 5 and <13 years
- With mild to moderate intellectual deficiency
- attending school either at ULIS or IME in the Rhône department.
Exclusion Criteria:
- No insurance coverage
- No parents agreement
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
IME attending ID children
Children with mild to moderate Intellectual Deficiency attending school at IME (Instituts Médico-Educatifs, which are special schools mandated to accommodate children and young people with Intellectual Disability at any level of disability).
|
Cognitive, adaptive, behavioral and academic assessment will be performed if not available in the records, using WISC-IV, VABS, GECEN and an academic skills rating form.
|
ULIS attending ID children
Children with mild to moderate Intellectual Deficiency attending school at ULIS (Unités Localisées pour l'Inclusion Scolaire, which enables disabled children to attend regular schools)
|
Cognitive, adaptive, behavioral and academic assessment will be performed if not available in the records, using WISC-IV, VABS, GECEN and an academic skills rating form.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of the ID assessment kit results in the records
Time Frame: within one year before the latest child orientation decision
|
The primary outcome measure consists of the presence of the results of the neuropsychological tests included in the ID assessment kit: WISC-IV (IQ), Vineland Adaptive Behavioral Scale II, GECEN rating form, and an academic skills rating form (GEVA-SCO), in the records from the MDPH and the school records (ULIS or IME), and dated from within one year before the latest child orientation decision.
|
within one year before the latest child orientation decision
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of the ID assessment kit results in the records
Time Frame: within one year before the inclusion
|
Presence of the results of the neuropsychological tests included in the ID assessment kit: WISC-IV (IQ), Vineland Adaptive Behavioral Scale II, GECEN rating form, and an academic skills rating form (GEVA-SCO), in the records from the MDPH and the school records (ULIS or IME), and dated from within a year before the inclusion in the study.
|
within one year before the inclusion
|
List of tests available in the children' records, other than the ones from the ID kit.
Time Frame: within one year before the latest child orientation decision
|
All the available tests will be listed.
|
within one year before the latest child orientation decision
|
List of tests available in the children's records, other than the ones from the ID kit.
Time Frame: within a year before the inclusion
|
All the available tests will be listed
|
within a year before the inclusion
|
WISC-IV (Wechsler Intelligence Scale for Children 4th edition)
Time Frame: within one year before the latest child orientation decision
|
The Intellectual Quotient of the patient will be assessed using a Wechsler scale, adapted to the age of the patient (WISC-IV).
|
within one year before the latest child orientation decision
|
Vineland Adaptive Behavioral Scale II
Time Frame: within one year before the latest child orientation decision
|
The Vineland adaptive behavioral scale performed during a semi-structured interview of each child's parents, will allow to assess the adaptive behavior of the child (including communication, daily living skills, socialization, motricity and the global adaptive score).
|
within one year before the latest child orientation decision
|
GECEN rating form (Grille d'Evaluation Comportementale pour Enfants Nisonger
Time Frame: within one year before the latest child orientation decision
|
The GECEN rating form (Grille d'Evaluation Comportementale pour Enfants Nisonger) is the French translation of the Nisonger Child Behavior Rating Form and will allow the assessment of behavior disorders including: conduct disorders, anxiety, hyperactivity, automutilation/stereotyped behavior, self-isolation/rituals, sensitivity/susceptibility.
|
within one year before the latest child orientation decision
|
an academic skills rating form
Time Frame: within one year before the latest child orientation decision
|
The academic skills rating form will assess 4 domains: the spoken and the written language, the "discovery of the world", and "being a student".
|
within one year before the latest child orientation decision
|
Rehabilitation programs
Time Frame: one year after Day 0
|
We will record from the MDPH files the type of rehabilitations that the children had at the latest child orientation decision.
|
one year after Day 0
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Vincent Des PORTES, MD, Hospices Civils de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL15_0257
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disability, Intellectual
-
Vestvagoy MunicipalityUniversity of Oslo; University of TromsoActive, not recruitingDisability, Developmental | Disabilities, IntellectualNorway
-
University of California, San FranciscoDoBrain Inc.RecruitingMild Intellectual Disability | Borderline Intellectual FunctioningUnited States
-
KoraalUniversity of Amsterdam; Zuyd University of Applied SciencesActive, not recruitingMild Intellectual Disability | Borderline Intellectual FunctioningNetherlands
-
University of ExtremaduraUniversity of CadizCompletedDisability Physical | Disabilities Multiple | Disability, Intellectual | Disability Hearing | Disability, VisionSpain
-
University of the Basque Country (UPV/EHU)Active, not recruiting
-
Chinese University of Hong KongActive, not recruitingIntellectual Disability, MildHong Kong
-
Assistance Publique - Hôpitaux de ParisPlateforme PRISMECompletedAttention Deficit in Intellectual DisabilityFrance
-
Aleksandra KiperRecruitingIntellectual Disability, MildPoland
-
Centre Hospitalier Universitaire de BesanconCompletedSevere Intellectual DisabilityFrance
-
Nantes University HospitalNantes Genomics platformCompleted
Clinical Trials on Cognitive, adaptive, behavioral and academic assessment
-
Hospices Civils de LyonUnknownX-linked Mental RetardationFrance
-
Haukeland University HospitalWestern Norway University of Applied SciencesRecruitingCognitive Impairment | Amyotrophic Lateral SclerosisNorway
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Fatigue | Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Recurrent Endometrial Carcinoma | Anxiety Disorder | Ovarian Sarcoma | Recurrent Uterine Sarcoma | Recurrent Breast Cancer | Leydig Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Ovarian... and other conditionsUnited States
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
UConn HealthNational Institute of Dental and Craniofacial Research (NIDCR)RecruitingTemporomandibular Joint Disorders | Orofacial PainUnited States
-
St. Jude Children's Research HospitalCompletedSickle Cell DiseaseUnited States
-
Sheba Medical CenterMaccabi Healthcare Services, IsraelCompleted
-
Rutgers, The State University of New JerseyNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Syracuse University and other collaboratorsCompleted
-
Institut National de la Santé Et de la Recherche...UnknownParkinson Disease | Depressive Symptoms | Frontotemporal Dementia | ApathyFrance
-
Karolinska InstitutetCompletedDepression | Anxiety Disorders and Symptoms | Life StyleSweden